Basics Cardiff Oncology, Inc. IPO Date: August 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $142.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 4.09% Avg Daily Range (30 D): $0.06 | 2.66% Avg Daily Range (90 D): $0.06 | 2.62% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): .68M Avg Daily Volume (90 D): 1.1M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 196 Avg Trade Size (Sh.) (90 D): 211 Institutional Trades Total Inst.Trades: 175 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $1.2M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.14M Avg Closing Trade (30 D): $1.63M Avg Closing Trade (90 D): $1.63M Avg Closing Volume: 378.1K     News Nov 24, 2025 @ 12:00 PM Cardiff Oncology to Present at the Piper Sandler 3... Source: Cardiff Oncology, Inc. Nov 12, 2025 @ 6:00 PM KRAS Inhibitors Market to Witness Explosive Growth... Source: Delveinsight Mar 8, 2025 @ 12:33 PM Why the Global Cancer Market Could Surpass $900 Bi... Source: Prnewswire Dec 10, 2024 @ 12:20 PM Cardiff Oncology Prices Oversubscribed $40 Million... Source: Globe Newswire Dec 10, 2024 @ 11:00 AM Cardiff Oncology Announces Positive Initial Data f... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.17 $-.21 $-.2 Diluted EPS $-.17 $-.21 $-.2 Revenue $ .12M $ .12M $ .11M Gross Profit $ $ $ Net Income / Loss $ -11.26M $ -13.94M $ -13.43M Operating Income / Loss $ -11.97M $ -14.78M $ -14.38M Cost of Revenue $ $ $ Net Cash Flow $ -.65M $ -13.31M $ -27.38M PE Ratio     Splits Feb 20, 2019:   1:6 Jun 04, 2018:   1:12 May 30, 2012:   1:6